Jeffrey D. Kearns
- Cancer Research top 2%
- NF-κB Signaling Pathways 13
- Immunology top 2%
- Immune Response and Inflammation 12
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions 9
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 3
- Molecular Biology top 10%
- Viral Infectious Diseases and Gene Expression in Insects 3
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Alexander HoffmannShannon L. WernerEllen L O'DeaSoumen BasakGourisankar GhoshChristine HuangHana KimCarl F. Ware
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Journal of Clinical Oncology (3 papers)Molecular Cancer Therapeutics (2 papers)Immunity (2 papers)
- Partner nations
- United StatesSwitzerlandChina
In The Last Decade
Jeffrey D. Kearns
32 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 818
- Immunology 920
- Oncology 506
- Molecular Biology 725
- Radiology, Nuclear Medicine and Imaging 143
Countries citing papers authored by Jeffrey D. Kearns
This map shows the geographic impact of Jeffrey D. Kearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Kearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Kearns more than expected).
Fields of papers citing papers by Jeffrey D. Kearns
This network shows the impact of papers produced by Jeffrey D. Kearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Kearns. The network helps show where Jeffrey D. Kearns may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey D. Kearns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 16 | |
| 4 | 2016 | 11 | |
| 5 | 2016 | 18 | |
| 6 | 2016 | 1 | |
| 7 | 2015 | 46 | |
| 8 | 2015 | 38 | |
| 9 | 2013 | 35 | |
| 10 | 2013 | 46 | |
| 11 | 2012 | 152 | |
| 12 | 2011 | 22 | |
| 13 | 2011 | 0 | |
| 14 | 2011 | 35 | |
| 15 | 2008 | 22 | |
| 16 | 2008 | 56 | |
| 17 | 2008 | 81 | |
| 18 | 2008 | 173 | |
| 19 | 2007 | 310 | |
| 20 | 2006 | 187 |
About Jeffrey D. Kearns
Jeffrey D. Kearns is a scholar working on Cancer Research, Oncology and Immunology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (13 papers), Immune Response and Inflammation (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Cytokine Signaling Pathways and Interactions (9 papers), HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (6 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Cancer Research (818 citations), Immunology (920 citations) and Oncology (506 citations). Jeffrey D. Kearns has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Alexander Hoffmann, Shannon L. Werner, Ellen L O'Dea, Soumen Basak, Gourisankar Ghosh, Christine Huang, Hana Kim, Carl F. Ware, Inder M. Verma and Vinay Tergaonkar. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer Therapeutics, Immunity, Journal of Biological Chemistry and Journal of Pharmacokinetics and Pharmacodynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.